Neuroone Medical Technologies Corp reports results for the quarter ended in December - Earnings Summary

Neuroone Medical Technologies

15/02/2022 17:27

* Neuroone Medical Technologies Corp  NMTC.OQ  reported a
quarterly adjusted loss of 18 cents​​ per share for the quarter
ended in December. The mean expectation of two analysts for the
quarter was for a loss of 18 cents per share.
    * Revenue was $33.75 thousand​;  analysts expected zero. 
    * Neuroone Medical Technologies Corp's reported EPS for the
quarter was a loss of 18 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Neuroone Medical Technologies Corp shares had risen
by 50.0%
this quarter.
    * The company reported a quarterly loss of $2.81 million.
    * Wall Street's median 12-month price target for Neuroone
Medical
Technologies Corp is $5.88 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 15 at 05:27 p.m.
 ​All figures in US dollars unless otherwise stated